Results for untargeted MS search on m/z: (+/-) mode
Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
---|---|---|---|---|---|---|---|---|---|---|
AN001155 | 88.0153 | 0.89 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 90.0308 | 0.75 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 112.0166 | 1 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 118.0268 | 1.31 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 118.0633 | 3.59 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 129.0425 | 1.16 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 130.0262 | 0.84 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 130.0632 | 4.7 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 131.0944 | 1.58 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 133.0337 | 0.65 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 134.0198 | 0.72 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 138.0317 | 8.34 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | L-[15N]ANTHRANILIC ACID [ISTD] (CAS# ); (M-H)- | 138.0448 | 5.41 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001155 | 138.0448 | 5.45 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 147.0533 | 0.8 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 147.0894 | 3.3 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 147.9915 | 0.84 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 152.0327 | 1.28 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 159.9855 | 0.57 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 161.0503 | 1.81 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 162.0526 | 1.59 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | PROCOLLAGEN 5-HYDROXY-L-LYSINE (CAS# 1190-94-9); (M-H)- | 162.0995 | 0.57 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001155 | 165.0791 | 2.55 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 168.0282 | 0.97 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 173.0685 | 1.62 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 173.9986 | 3.01 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 174.0165 | 1.16 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 175.9636 | 0.56 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | L-ARGININE-(GUANIDINEIMINO-15N2) [ISTD] (CAS# ); (M-H)- | 176.1054 | 0.62 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001155 | 179.0585 | 4.85 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 180.0636 | 0.72 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 180.0647 | 4.45 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 181.0738 | 1.35 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 188.0517 | 0.91 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 189.0627 | 1.35 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 189.9919 | 2.55 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 190.0465 | 1.44 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 193.0562 | 12.82 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 193.0740 | 5.68 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 194.0306 | 0.79 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 194.0942 | 15.21 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 196.0549 | 0.71 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 196.0586 | 4.14 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 198.0505 | 4.77 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 200.0145 | 6.91 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 200.0436 | 0.72 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 201.0637 | 1.7 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 201.1015 | 3.94 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 202.0299 | 8.11 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 202.0455 | 0.96 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 204.0091 | 4.56 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 204.0576 | 1.56 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 204.0698 | 0.77 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 204.0715 | 1.59 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 204.0895 | 3.68 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 205.0739 | 7.47 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 206.0193 | 8.34 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 206.0322 | 5.41 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | L-TRYPTOPHAN-15N2 [ISTD] (CAS# ); (M-H)- | 206.0845 | 3.68 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001155 | 207.9603 | 3.55 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 208.0554 | 0.76 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 210.1258 | 13.24 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 213.0099 | 3.31 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 216.0385 | 0.67 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 217.0577 | 1.37 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 218.0245 | 6.92 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 218.0365 | 0.68 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 219.0741 | 1.58 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 219.1113 | 3.43 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 219.1126 | 3.94 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 223.0345 | 2.55 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 226.0718 | 3.68 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 227.9412 | 5.41 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 230.0614 | 12.33 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 230.1628 | 3.65 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 231.0196 | 5.1 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 232.0026 | 5.99 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 233.0669 | 2.55 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 233.9995 | 7.05 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 234.1617 | 19.78 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 241.0588 | 1.36 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 243.1833 | 15.9 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 244.0700 | 1.39 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 244.0702 | 1.36 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 246.1204 | 1.54 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 246.1211 | 2.5 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 247.0457 | 4.86 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 248.0522 | 4.57 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 251.1525 | 21.15 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 254.2250 | 22.63 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 254.9752 | 2.56 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 256.0019 | 5.36 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 256.0951 | 10.07 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 256.1216 | 9.43 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 256.2404 | 22.88 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 257.0653 | 0.74 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 258.0849 | 1.5 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 262.0484 | 3.68 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 262.0775 | 0.7 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 264.1114 | 5.28 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 266.1556 | 20.72 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 268.0829 | 1.69 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 268.1302 | 18.74 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 272.0776 | 3.68 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 272.2357 | 22.47 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 273.0296 | 3.29 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 277.0700 | 3.3 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 278.1137 | 13.24 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 278.1530 | 20.14 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 278.2232 | 22.81 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 280.0476 | 0.79 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 280.2409 | 22.76 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 282.1079 | 4.15 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 282.2560 | 22.96 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 284.0759 | 2.33 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 284.2717 | 23.21 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 287.0983 | 3.33 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 287.0999 | 3.95 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 288.0287 | 4.81 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 289.1272 | 1.26 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 289.9444 | 0.56 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 290.0775 | 1.26 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 290.1094 | 7.7 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 293.1464 | 1.86 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 294.0622 | 2.51 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 294.1867 | 22.27 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 296.1974 | 22.49 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 296.2352 | 21.53 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 297.0903 | 4.54 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 298.0461 | 8.33 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 298.0720 | 5.41 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 298.2505 | 22.41 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 300.1027 | 21.81 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 300.2663 | 22.44 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 302.2251 | 22.55 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 304.0906 | 2.54 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 304.2406 | 22.73 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 307.0830 | 0.71 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 307.0844 | 1.01 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 308.0040 | 3.47 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 308.1190 | 10.38 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 309.1032 | 0.71 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 309.1063 | 0.94 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 309.1436 | 3.9 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 310.1167 | 2.61 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 312.1768 | 21.86 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 314.0721 | 0.83 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 314.2472 | 22.71 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 317.0118 | 3.94 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 321.0705 | 1.38 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 322.0700 | 0.7 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 322.2129 | 22.6 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 323.3658 | 22.44 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 324.0835 | 0.69 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 324.2285 | 22.88 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 326.1152 | 2.25 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 326.1924 | 22.45 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 327.0362 | 8.34 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 327.0491 | 5.42 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 327.0924 | 1.81 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 327.0959 | 2.41 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 327.1324 | 2.9 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 328.1354 | 22.5 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 328.2414 | 22.72 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 329.1082 | 21.81 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 329.9630 | 3.67 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 330.2544 | 22.86 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 331.0632 | 13.23 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 331.1039 | 4.83 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 332.2742 | 22.86 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 334.0981 | 7.69 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 334.0993 | 9.43 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 334.1008 | 1.42 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 334.1437 | 20.72 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 336.0716 | 0.7 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 336.1562 | 5.76 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 337.1404 | 10.5 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 340.0671 | 3.69 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 340.0841 | 13.24 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 340.2076 | 22.94 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 340.2232 | 22.46 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 340.2421 | 22.49 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 342.1523 | 22.7 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 344.9829 | 3.28 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 345.0403 | 0.96 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 345.1380 | 2.55 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 346.1004 | 13.24 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 346.1423 | 8.58 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 346.2132 | 22.78 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 348.0415 | 5.39 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 348.2287 | 22.76 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 349.1747 | 4.37 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 350.2442 | 22.95 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 351.1554 | 6.18 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 352.1380 | 2.55 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 352.2598 | 23.22 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 354.0566 | 15.2 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 354.0568 | 11.33 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 354.1510 | 22.62 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 355.1573 | 22.56 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 356.0810 | 7.69 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 356.1666 | 22.88 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 357.1402 | 22.52 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 358.0400 | 1.06 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 358.0623 | 0.85 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 361.0950 | 2.54 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 365.2221 | 22.87 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 366.1427 | 2.34 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 370.1821 | 23.04 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 370.2159 | 22.55 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 372.2284 | 22.73 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 373.1130 | 1.23 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 375.2532 | 17.38 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 376.0390 | 11.33 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 376.1073 | 10.39 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 378.1508 | 22.66 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 379.1058 | 1.78 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 380.1642 | 21.87 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 380.1662 | 22.75 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 382.0381 | 1.07 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 382.1121 | 4.51 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 382.1825 | 22.95 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 383.3014 | 22.37 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 384.1207 | 1.56 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 384.1977 | 23.22 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 385.1717 | 22.86 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 386.1346 | 3.94 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 386.1767 | 11.4 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 386.1959 | 22.82 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 389.1634 | 20.62 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 389.1638 | 20.73 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 389.2602 | 23.28 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 391.2481 | 19.26 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 391.2767 | 24.26 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 392.2150 | 22.88 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 392.2963 | 22.91 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 393.1218 | 2.51 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 394.1804 | 22.43 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 396.1710 | 13.47 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 396.2004 | 17.4 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 396.2280 | 22.69 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 398.0119 | 5.34 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 398.3771 | 23 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 400.1203 | 2.55 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 402.0871 | 12.87 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 402.0873 | 9.43 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 402.1519 | 22.54 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 404.1009 | 8.58 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 404.1673 | 22.73 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 405.0532 | 0.99 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 406.1994 | 13.48 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 408.0720 | 13.24 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 408.2161 | 13.92 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 411.1881 | 22.95 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 411.2432 | 22.51 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 411.3338 | 22.72 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 412.2144 | 23.09 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 413.2013 | 23.23 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 414.0878 | 13.24 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 414.1301 | 8.58 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 414.1505 | 6.2 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 414.1999 | 22.67 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 414.2087 | 15.58 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 415.1088 | 3.95 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 416.2138 | 22.73 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 418.2283 | 22.84 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 420.0552 | 2.55 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 420.1200 | 2.55 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 422.1509 | 16.54 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 422.1640 | 19.07 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 422.2369 | 22.26 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 422.3375 | 22.73 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 423.0952 | 1.25 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 423.1662 | 2.56 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 424.0682 | 7.7 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 425.1440 | 1.39 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 426.3721 | 22.98 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 428.1701 | 22.72 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 429.1971 | 23.17 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 430.0854 | 2.55 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 430.1609 | 3.68 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 430.1906 | 22.93 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 432.1794 | 16.54 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 432.1924 | 19.07 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 433.1786 | 22.75 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 435.2214 | 3.7 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 436.3555 | 23.05 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 438.0632 | 13.07 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 438.1701 | 14.82 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 440.2159 | 22.73 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 440.3523 | 22.8 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 441.1402 | 5.94 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 442.2339 | 13.24 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 444.0259 | 11.33 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 444.0919 | 10.39 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 444.1463 | 2.55 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 444.3292 | 22.65 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 446.2159 | 22.82 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 446.2163 | 22.88 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 446.2165 | 23.01 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 446.3399 | 22.78 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 447.3843 | 23.86 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 448.0020 | 3.25 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 448.1014 | 1.33 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 448.1428 | 18.18 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 448.3552 | 22.94 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 449.3149 | 20.7 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 449.3150 | 20.34 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 450.1154 | 1.9 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 450.2627 | 21.83 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 450.3684 | 22.97 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 453.2863 | 22.24 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 453.2870 | 22.31 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 453.3241 | 22.48 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 454.0870 | 1.65 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 454.1641 | 11.42 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 454.1848 | 22.88 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 458.1645 | 2.58 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 458.1877 | 22.67 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 458.2304 | 23 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 459.3414 | 22.45 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 460.1325 | 3.68 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 460.2030 | 3.3 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 460.2060 | 22.89 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 462.1312 | 4.27 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 462.2091 | 22.71 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 462.3330 | 22.86 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 464.2191 | 22.69 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 464.2212 | 22.89 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 464.3511 | 22.77 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 465.3095 | 18.95 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 466.3602 | 22.91 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 468.3286 | 22.82 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 468.3748 | 22.91 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 469.1376 | 1.23 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 469.2604 | 22.87 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 470.0734 | 12.84 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 470.3445 | 22.9 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 472.0892 | 8.58 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 472.3533 | 22.95 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 474.3711 | 23 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 475.2195 | 22.82 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 476.0591 | 13.24 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 476.1340 | 3.66 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 477.2865 | 22.22 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 477.2866 | 22.09 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 478.1882 | 22.72 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 479.3026 | 22.42 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 479.3030 | 22.36 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 480.2030 | 22.89 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 481.3176 | 22.69 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 481.3194 | 22.31 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 481.3198 | 22.5 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 482.0748 | 13.24 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 482.1011 | 1.04 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 482.1164 | 8.58 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 482.1876 | 22.72 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 482.1941 | 15.59 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 482.2846 | 20.49 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 483.3009 | 21.28 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 484.2030 | 22.8 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 486.2180 | 22.93 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 487.2886 | 24.64 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 490.1038 | 1.03 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 490.3699 | 22.8 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 492.1411 | 3.31 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 492.1570 | 3.68 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 492.3767 | 23 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 494.3945 | 23 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 496.3409 | 18.95 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 496.4117 | 23.06 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 498.0781 | 3.68 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 498.1448 | 3.68 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 499.2969 | 19.98 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 499.2976 | 19.65 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 499.9376 | 19.25 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 500.1469 | 3.95 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 500.3129 | 21.81 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 501.2868 | 22.13 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 502.1885 | 22.74 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 503.3007 | 22.34 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 504.1257 | 1.69 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 508.2017 | 22.74 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 508.2317 | 20.19 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 509.0593 | 1.6 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 509.3513 | 22.76 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 510.2179 | 13.24 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 512.0106 | 11.34 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 512.4012 | 22.81 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 513.2779 | 19.75 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 513.3069 | 21.64 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 513.3075 | 21.48 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 514.1061 | 1.56 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 515.2844 | 24.64 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 515.2946 | 18.06 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 516.3232 | 19.89 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 516.3764 | 22.96 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 517.3017 | 17.82 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 517.3024 | 20.35 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 518.1628 | 3.3 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 518.1770 | 6.19 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 518.2472 | 21.8 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 518.3962 | 22.92 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 519.1938 | 2.56 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 520.4153 | 23.08 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 521.0675 | 16.55 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 521.2745 | 22.31 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 521.3110 | 22.47 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 523.4975 | 24.1 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 524.3357 | 19.68 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 524.3889 | 23.1 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 525.2851 | 22.12 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 525.2861 | 22.05 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 525.3068 | 22.83 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 525.3434 | 22.45 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 526.1798 | 22.67 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 526.3521 | 19.89 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 527.1745 | 13.26 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 527.3019 | 22.29 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 527.3224 | 22.07 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 527.3230 | 22.44 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 527.3533 | 22.6 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 528.1826 | 3.3 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 528.1901 | 22.88 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 529.3173 | 22.42 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 529.3174 | 22.33 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 531.2790 | 24.64 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 532.2027 | 22.73 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 532.2836 | 22.52 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 532.3133 | 17.9 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 532.7397 | 22.44 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 533.3173 | 22.29 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 534.3933 | 22.79 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 534.4623 | 22.88 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 535.1459 | 8.58 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 535.2604 | 19.75 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 535.4980 | 24.01 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 536.3088 | 22.84 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 537.5135 | 24.38 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 538.0607 | 12.83 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 538.3275 | 22.89 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 538.4215 | 22.85 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 539.3236 | 21.8 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 539.3244 | 21.93 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 539.3418 | 22.64 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 539.4923 | 23.89 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 539.5289 | 24.61 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 540.2578 | 14.48 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 540.4371 | 22.85 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 541.0618 | 0.74 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 541.0624 | 1.09 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 541.3388 | 22.35 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 541.3396 | 22.22 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 542.3458 | 17.9 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 542.3465 | 18.22 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 542.3465 | 18.64 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 543.0427 | 2.54 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 543.3409 | 19.9 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 544.0465 | 13.24 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 544.0876 | 8.58 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 545.2738 | 22.09 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 545.2741 | 22.13 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 545.4583 | 23.89 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 546.1758 | 22.73 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 547.2907 | 22.44 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 547.2925 | 22.82 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 548.1907 | 22.91 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 549.3049 | 22.7 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 550.0624 | 13.24 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 550.1035 | 8.58 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 551.4928 | 23.75 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 551.5301 | 24.67 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 552.1921 | 22.8 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 553.2773 | 24.64 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 553.3713 | 22.63 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 553.4742 | 23.59 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 553.5091 | 24.09 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 554.2059 | 22.89 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 555.3139 | 22.15 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 555.3481 | 22.53 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 555.4875 | 23.9 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 555.5241 | 24.39 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 556.2191 | 23.21 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 556.2832 | 22.57 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 557.2270 | 24.64 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 557.3331 | 19.52 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 557.5042 | 24.1 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 558.3550 | 22.87 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 558.4676 | 23.75 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 559.3354 | 18.95 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 560.4128 | 22.89 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 563.3046 | 24.64 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 563.3205 | 21.86 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 563.5291 | 24.55 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 565.3388 | 22.17 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 565.3526 | 23.52 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 565.3531 | 22.58 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 565.5449 | 25.04 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 566.0548 | 0.83 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 567.2553 | 24.64 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 567.2844 | 19.65 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 567.3540 | 22.37 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 567.3558 | 22.47 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 569.2742 | 22.13 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 569.3700 | 22.7 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 569.3700 | 22.77 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 569.5028 | 24.11 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 571.3662 | 25.16 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 571.5182 | 24.34 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 572.1919 | 13.24 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 572.2928 | 3.65 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 572.2979 | 22.77 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 572.4807 | 23.89 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 573.3170 | 22.39 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 574.4640 | 23.09 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 576.1921 | 22.75 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 577.2838 | 24.64 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 578.2072 | 13.24 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 578.4934 | 23.11 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 579.1371 | 1.8 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 579.5243 | 24.21 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 580.0354 | 1.11 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 581.2973 | 21.65 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 581.3444 | 22.24 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 581.3461 | 22.72 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 581.5033 | 24.01 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 581.5398 | 24.57 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 582.0577 | 3.66 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 582.4629 | 22.82 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 583.5191 | 24.39 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 584.2631 | 23.29 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 584.3609 | 22.95 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 585.2895 | 20.32 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 585.5346 | 24.61 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 586.4892 | 22.86 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 586.4947 | 24.11 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 587.3224 | 21.99 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 587.5131 | 24.67 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 588.1453 | 22.66 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | GUANOSINE 5'-DIPHOSPHO-BETA-L-FUCOSE (CAS# 0); (M-H)- | 589.0830 | 1.02 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001155 | 589.0832 | 1.02 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 589.3001 | 22.47 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 589.3385 | 22.17 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 590.1612 | 22.88 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 591.3587 | 22.24 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 591.3587 | 22.42 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 592.4734 | 22.94 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 593.2731 | 22.11 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 593.6795 | 22.44 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 594.4163 | 23.45 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 594.4889 | 22.92 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 595.2904 | 22.2 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 595.2906 | 22.27 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 595.3137 | 22.42 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 595.3417 | 22.59 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 595.4056 | 22.88 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 595.5186 | 24.26 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 596.1768 | 22.87 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 596.2992 | 22.32 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 597.3067 | 22.47 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 597.3423 | 21.4 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 597.5337 | 24.66 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 598.1807 | 22.78 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 598.3151 | 23.05 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 598.5019 | 23.91 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 599.2179 | 22.86 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 599.5138 | 23.63 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 599.5491 | 24.91 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 600.1876 | 22.74 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 600.3286 | 23.86 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 600.3290 | 23.64 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 600.5113 | 24.41 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 602.5231 | 24.59 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 603.5358 | 25.34 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 604.3064 | 22.85 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 604.4566 | 23.04 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 606.3082 | 22.99 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 606.4627 | 22.74 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 607.0828 | 0.81 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 607.3102 | 21.93 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 607.5177 | 24.18 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 609.3260 | 22.23 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 609.3267 | 22.35 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 609.5347 | 24.55 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 611.5504 | 25.04 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 612.0318 | 13.24 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 612.0743 | 8.58 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 612.1432 | 22.66 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 612.1517 | 0.73 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | GLUTATHIONE (CAS# 27025-41-8); (M-H)- | 612.1533 | 1.37 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001155 | 612.1533 | 1.37 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 613.3365 | 22.18 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 613.5649 | 25.34 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 614.1620 | 22.78 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 614.4626 | 22.85 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 614.5260 | 24.67 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 615.2406 | 19.57 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 615.2795 | 22.82 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 615.2814 | 22.49 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 615.5413 | 25.46 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 616.1776 | 22.95 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 616.4712 | 23.07 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 617.2940 | 22.7 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 618.0491 | 13.24 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 618.0911 | 8.59 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 618.1934 | 23.21 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 618.4839 | 23.12 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 620.1804 | 22.82 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 620.2966 | 22.42 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 620.4349 | 24.37 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 622.1977 | 22.93 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 622.4458 | 23.78 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 623.3392 | 22.59 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 623.5494 | 24.89 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 625.2686 | 19.9 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 625.2690 | 19.56 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 625.5649 | 25.46 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 625.5652 | 25.35 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 626.3434 | 22.89 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 626.5249 | 24.53 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 627.2711 | 0.5 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 627.2875 | 22.39 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 627.5393 | 25.28 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 627.5421 | 24.39 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 627.5422 | 24.65 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 627.5455 | 24.54 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 627.5816 | 24.97 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 628.2918 | 18.95 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 628.4047 | 22.88 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 628.5403 | 25.05 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 629.0673 | 0.83 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 629.2468 | 3.12 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 629.5525 | 25.95 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 630.5522 | 25.31 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 633.3256 | 22.13 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 633.3257 | 22.21 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 634.1338 | 1.38 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 635.3438 | 22.48 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 636.1479 | 0.98 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 636.4303 | 23.01 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 637.2609 | 22.05 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 637.2621 | 22.16 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 637.3591 | 22.73 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 637.3604 | 22.77 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 637.4333 | 24.41 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 637.5654 | 25.28 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 638.1608 | 22.74 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 639.5802 | 25.52 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 639.5812 | 25.95 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 641.5956 | 26.36 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 643.4055 | 22.71 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | C12 GALACTOSYL(BETA) CERAMIDE (D18:1/12:0) (CAS# 41613-14-3); (M+CL)- | 643.5085 | 22.86 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001155 | 644.1794 | 22.76 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 645.0386 | 0.84 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 646.1263 | 18.82 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 647.3677 | 19.55 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 647.6228 | 27.39 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 648.4644 | 25.06 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 649.2800 | 21.64 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 650.1066 | 1.35 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 650.1084 | 0.74 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 650.4499 | 22.81 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 651.2744 | 22.45 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 651.4664 | 23.21 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 651.5819 | 25.71 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 652.1231 | 1.02 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 653.2745 | 20.35 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 653.2766 | 20.68 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 653.5938 | 26.5 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 654.3094 | 23.19 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 654.3114 | 22.79 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 654.4765 | 22.94 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 655.3109 | 21.96 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 655.5689 | 26.28 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 655.5760 | 25.15 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 655.6116 | 25.82 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 656.1364 | 22.71 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 656.1561 | 18.82 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 656.2330 | 3.68 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 656.4463 | 22.89 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 656.5740 | 25.98 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 657.2879 | 22.47 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 657.3239 | 22.18 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 657.3277 | 22.06 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 657.5835 | 27.21 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 658.1478 | 22.88 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 659.3471 | 22.38 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 660.5194 | 24 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 661.2630 | 22.13 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 661.5651 | 24.87 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 662.1485 | 22.7 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 662.4044 | 22.68 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 662.5391 | 24.2 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | NAD (CAS# 53-84-9); (M-H)- | 663.1094 | 1.04 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001155 | 663.1100 | 1.04 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 663.1104 | 0.75 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 663.3012 | 22.44 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 663.3630 | 18.95 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 663.5811 | 25.41 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 664.1674 | 22.87 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 664.4330 | 22.87 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 665.1258 | 1.88 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 665.5969 | 26.26 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 666.0741 | 1.37 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 666.1833 | 3.68 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 667.2062 | 22.86 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 667.6126 | 26.53 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 667.6127 | 27.21 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 668.3159 | 23.87 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 668.7126 | 22.44 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 669.5867 | 26.73 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 669.6283 | 27.77 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 670.4317 | 22.87 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 671.2991 | 22.49 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 671.6000 | 28.03 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 672.2758 | 22.55 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 672.2922 | 22.89 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 672.4065 | 24.4 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 673.1461 | 18.82 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 674.3044 | 22.9 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 674.4222 | 24.6 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 675.2977 | 21.93 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 677.3141 | 22.35 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 677.3166 | 22.25 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 677.5956 | 25.9 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 678.4426 | 24.39 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 679.6117 | 26.75 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 679.6125 | 26.93 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 680.0176 | 13.24 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 680.0595 | 8.58 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 680.4192 | 23.98 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 681.2521 | 22.2 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 681.5852 | 26.46 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 681.6281 | 28.03 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 682.2297 | 3.68 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 682.3046 | 22.55 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 682.4353 | 24.4 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 682.4489 | 22.91 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 682.5856 | 26.3 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 683.2721 | 22.45 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 683.4445 | 23.79 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 683.6006 | 27.68 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 683.6092 | 25.41 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 683.6428 | 27 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 684.1658 | 22.93 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 684.2730 | 2.56 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 684.4492 | 24.61 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 684.4561 | 23.01 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 684.6031 | 27.22 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 685.2810 | 22.69 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 685.4513 | 22.88 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 685.4576 | 23.62 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 685.4637 | 24.11 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 685.6150 | 28.98 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 686.0767 | 8.58 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 686.1794 | 23.22 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 686.4658 | 23.19 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 687.5839 | 25.19 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 688.1672 | 22.78 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 688.5480 | 24.6 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 689.5010 | 24.24 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 689.5968 | 25.72 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 690.1769 | 22.95 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 690.1783 | 7.7 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 691.3279 | 22.57 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 691.5181 | 24.55 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 691.6124 | 26.46 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 692.1952 | 23.21 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 692.4108 | 22.72 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 692.4307 | 25.75 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 693.6283 | 27.47 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 694.3310 | 22.88 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 694.4489 | 26.5 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 695.2897 | 22.19 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 695.6429 | 28 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 695.6440 | 28.98 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 696.3882 | 22.76 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 696.4346 | 22.75 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 696.4513 | 24.68 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 696.4633 | 27.63 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 696.6039 | 26.74 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 697.3128 | 22.4 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 699.5253 | 24.65 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 699.5653 | 23.88 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 699.9162 | 22.72 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 700.4381 | 25.09 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 700.4612 | 22.86 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 701.2948 | 3.31 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 701.3137 | 22.23 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 701.3141 | 22.16 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 701.5375 | 25.13 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 702.5192 | 24 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 703.3294 | 22.48 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 703.5170 | 24.56 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 704.5303 | 27.21 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 704.5397 | 24.49 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 705.2503 | 22.14 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 705.2504 | 22.05 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 705.3458 | 22.74 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 705.3463 | 22.77 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 707.6003 | 25.84 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 707.6040 | 24.34 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 707.6429 | 28.21 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 708.1654 | 13.24 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 708.4517 | 24.56 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 708.6034 | 26.46 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 709.6221 | 24.66 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 709.6235 | 25.49 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 710.1160 | 0.75 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 710.4666 | 25.1 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 710.6184 | 27.43 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 710.6198 | 27.71 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 711.4743 | 22.92 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 711.6328 | 26.53 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 712.4235 | 22.74 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 712.6337 | 28.98 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 713.2246 | 2.56 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 714.2677 | 8.58 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 715.5196 | 24.37 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 715.5607 | 23.73 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 715.6071 | 26.01 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 716.4695 | 22.94 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 717.5327 | 24.75 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 717.5348 | 23.5 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 718.4417 | 22.76 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 718.4478 | 26.01 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 719.2595 | 22.43 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 720.4630 | 26.86 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 720.5422 | 23.77 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 721.2662 | 20.34 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 721.5121 | 24.24 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 721.5290 | 27.21 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 721.6591 | 29.21 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 722.4684 | 22.9 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 722.4793 | 27.99 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 723.5214 | 24.61 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 724.1223 | 22.68 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 724.2077 | 3.67 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 724.4957 | 29.56 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 724.9867 | 2.55 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 725.2737 | 22.48 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 725.3105 | 22.21 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 725.3120 | 22.12 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 726.1354 | 22.87 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 727.5546 | 25.3 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 727.6329 | 25.85 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 728.5091 | 24.06 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 729.5418 | 24.66 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 729.5703 | 26.01 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 730.5437 | 27.72 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 730.5464 | 27.41 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 731.2890 | 22.43 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 731.5513 | 23.67 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 732.1547 | 22.87 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 732.5593 | 28.98 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 732.5648 | 25.19 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 734.1420 | 7.69 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 734.5554 | 23.96 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 735.1913 | 22.89 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 736.3045 | 23.93 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 736.6958 | 22.44 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 737.5333 | 23.99 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 737.5421 | 24.91 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 738.4309 | 22.85 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 738.5012 | 25.94 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 739.2784 | 22.29 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 739.5167 | 24.33 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 740.2786 | 22.87 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 741.3432 | 6.78 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 741.5328 | 24.59 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 742.1007 | 18.82 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 743.0750 | 0.9 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 743.5482 | 24.74 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 743.5501 | 25.01 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 743.5543 | 23.61 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 744.4644 | 26.8 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 745.3010 | 22.36 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 745.3048 | 22.31 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 745.5273 | 26.48 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 745.5628 | 25.51 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 746.5570 | 23.91 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 747.5207 | 24.58 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 747.5232 | 24.53 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 747.5424 | 27.65 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 747.5432 | 27.43 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 747.5853 | 24.04 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 748.1266 | 22.67 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 748.5737 | 24.2 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 749.5301 | 23.92 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 749.5391 | 24.73 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 749.5593 | 28.98 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 750.1408 | 22.78 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 750.4273 | 22.83 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 750.5804 | 24.29 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 751.2504 | 22.43 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 751.5376 | 24.3 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 751.5522 | 25.14 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 751.5524 | 25.31 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 752.1516 | 22.96 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 752.4451 | 22.73 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 753.2678 | 22.7 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 753.5319 | 24.63 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 753.5545 | 27.21 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 754.1676 | 23.21 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 756.1526 | 22.74 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 756.5012 | 27.21 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 757.4879 | 24.21 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 758.1681 | 22.96 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 759.5008 | 24.63 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 759.5844 | 24.1 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 760.1839 | 23.22 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 761.0824 | 1.05 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 761.0846 | 0.82 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 761.5217 | 25.26 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 761.5228 | 25.08 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 761.5387 | 24.84 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 762.5868 | 24.48 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 763.5202 | 24.26 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 763.5553 | 25.06 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 764.5139 | 26.3 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 765.3003 | 22.48 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 765.5325 | 24.47 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 765.5369 | 24.57 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 765.5671 | 25.51 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 766.5282 | 27.21 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 767.3196 | 22.77 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 767.5464 | 24.8 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 767.5481 | 24.97 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 769.3000 | 22.1 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 769.3004 | 22.17 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 769.5360 | 25.13 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 769.5598 | 25.27 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 770.4799 | 27.11 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 771.3157 | 22.48 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 771.5043 | 24.56 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 773.2352 | 22.14 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 773.2362 | 22.05 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 773.3317 | 22.75 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 773.3324 | 22.76 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 773.4671 | 26.83 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 773.5372 | 24.64 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 773.6024 | 24.35 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 774.2032 | 1.56 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 774.5880 | 24.35 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 775.5360 | 24.07 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 775.5535 | 25.2 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 776.5942 | 24.8 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 777.5521 | 24.42 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 777.5572 | 26.46 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 777.5660 | 25.3 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 777.5681 | 25.46 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 778.5320 | 26.73 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 779.5679 | 24.9 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 779.5735 | 27.4 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 779.5832 | 26.02 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 780.5466 | 28.03 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 781.5674 | 25.16 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 781.5700 | 24.9 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 781.5885 | 28.98 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 782.2534 | 8.58 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 782.5162 | 27.41 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 783.5043 | 24.35 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 783.5088 | 25.09 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 783.5090 | 25.25 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 783.6594 | 25.85 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 784.4398 | 22.93 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 784.5324 | 28.98 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 785.1576 | 6.32 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 785.5190 | 24.78 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 787.2440 | 22.45 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 787.5361 | 25.3 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 787.5373 | 25.48 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 787.5654 | 25.83 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 787.6187 | 24.64 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 788.5280 | 23.77 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 789.5345 | 24.39 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 789.9810 | 22.84 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 789.9818 | 22.59 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 789.9820 | 22.73 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 789.9827 | 22.59 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 790.5293 | 26.47 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 791.5197 | 24.41 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 791.5258 | 24.61 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 791.5499 | 24.86 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 791.5618 | 24.69 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 791.6001 | 25.56 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 792.1038 | 22.63 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 792.5433 | 27.4 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 792.5447 | 27.4 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 792.5447 | 27.71 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 793.2605 | 22.44 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 793.2983 | 22.12 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 793.3006 | 22.15 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 793.5433 | 24.61 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 793.5601 | 24.95 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 793.5632 | 25.09 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 793.5637 | 25.09 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 794.1231 | 22.88 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 794.5607 | 28.98 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 795.5801 | 25.55 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 797.5839 | 26.6 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 797.5848 | 26.43 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 798.6707 | 22.44 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 799.2769 | 22.44 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 799.5348 | 24.01 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 799.5373 | 25.14 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 799.5404 | 23.68 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 800.1410 | 22.88 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 800.3965 | 22.88 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 801.5527 | 24.2 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 801.6306 | 24.99 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 802.5429 | 23.98 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 803.1793 | 22.86 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 803.5136 | 22.97 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 803.5675 | 24.57 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 804.2896 | 24.12 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 804.2902 | 23.83 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 804.6864 | 22.44 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 805.5844 | 25.02 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 807.2620 | 22.36 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 807.2642 | 22.36 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 807.5065 | 24.33 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 807.5987 | 25.71 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 809.5180 | 24.5 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 809.6755 | 25.98 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 811.2796 | 21.92 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 811.5346 | 25.85 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 811.5347 | 26.09 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 811.5348 | 24.97 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 811.5368 | 25.24 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 811.5378 | 25.42 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 811.5396 | 25.01 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 811.6909 | 27.03 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 813.2862 | 22.36 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 813.5449 | 24.24 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 813.5541 | 25.55 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 813.5587 | 23.88 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 813.5804 | 24.94 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 814.5529 | 23.87 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 814.6412 | 27.4 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 815.5141 | 24.52 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 815.5947 | 27 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 816.1323 | 23.22 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 816.5611 | 24.2 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 817.5257 | 24.73 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 817.5658 | 24.85 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 818.5688 | 24.21 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 818.5688 | 24.43 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 819.5260 | 24.3 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 819.5424 | 25.14 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 819.5441 | 25.31 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 820.1386 | 22.96 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 821.4864 | 26.83 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 821.5228 | 24.63 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 822.1540 | 23.21 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 823.4437 | 24.62 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 825.4352 | 26.84 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 825.5489 | 24.15 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 825.6309 | 24.64 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 826.1545 | 22.96 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 827.5676 | 24.51 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 827.5685 | 24.51 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 827.6485 | 25.21 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 828.1713 | 23.21 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 829.5812 | 24.78 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 829.5820 | 24.78 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 830.5725 | 24.49 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 831.5121 | 24.26 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 831.5174 | 23.88 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 831.5987 | 25.2 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 831.5990 | 25.19 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 832.6674 | 26.67 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 833.2856 | 22.48 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 833.5205 | 24.45 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 833.5276 | 25.24 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 833.5285 | 25.41 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 833.6150 | 25.88 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 835.3038 | 22.77 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 835.4668 | 26.84 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 835.5346 | 24.96 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 835.5350 | 25.55 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 835.5352 | 25.76 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 835.5357 | 24.96 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 835.5370 | 25.17 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 835.5391 | 25.32 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 837.2875 | 22.18 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 837.5009 | 22.96 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 837.5022 | 22.93 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 837.5030 | 22.78 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 837.5516 | 25.37 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 837.5529 | 25.57 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 839.3006 | 22.47 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 839.4941 | 24.56 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 839.5590 | 24.35 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 839.5675 | 26.1 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 839.5689 | 25.87 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 839.6017 | 25.07 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 840.3168 | 3.68 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 841.2215 | 22.14 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 841.2234 | 22.06 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 841.3181 | 22.75 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 841.3192 | 22.77 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 841.5267 | 24.64 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 841.5776 | 24.83 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 841.6611 | 25.52 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 842.5741 | 24.36 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 843.5241 | 24.08 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 843.5411 | 25.2 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 843.6788 | 26.4 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 844.5844 | 24.8 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 845.5389 | 24.42 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 845.5541 | 25.47 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 845.5548 | 25.26 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 845.5548 | 25.48 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 847.5552 | 24.89 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 847.5761 | 26.02 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 849.4721 | 24.73 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 851.4927 | 25.32 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 851.4964 | 25.11 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 851.5613 | 24.28 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 851.5613 | 24.44 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 851.5640 | 24.44 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 853.4044 | 22.35 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 853.5443 | 24.96 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 853.5458 | 24.78 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 853.5826 | 24.63 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 853.6632 | 25.33 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 855.1358 | 1.05 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 855.2688 | 22.48 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 855.5978 | 25 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 855.6003 | 25.19 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 855.6826 | 25.98 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 856.5159 | 23.76 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 856.6671 | 25.99 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 857.5239 | 24.36 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 857.6170 | 25.57 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 857.6979 | 27.03 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 857.9677 | 22.73 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 857.9710 | 22.59 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 858.6837 | 26.78 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 859.5078 | 24.61 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 859.5336 | 25.35 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 859.5379 | 24.87 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 859.5405 | 24.7 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 859.5475 | 24.7 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 860.0984 | 22.64 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 860.7017 | 28.16 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 861.2473 | 22.44 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 861.2881 | 22.17 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 861.5347 | 24.6 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 861.5501 | 25.09 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 861.5502 | 25.88 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 861.5511 | 26.1 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 861.5557 | 25.09 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 861.5565 | 25.28 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 861.6170 | 23.71 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 862.1119 | 22.89 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 863.5650 | 25.56 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 866.6579 | 22.44 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 867.2650 | 22.43 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 867.4748 | 24.95 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 867.5891 | 24.96 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 868.1295 | 22.88 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 868.3853 | 22.88 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 869.2712 | 3.68 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 870.5325 | 24.24 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 870.5346 | 23.98 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 871.1648 | 22.86 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 871.5542 | 24.57 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 872.2765 | 24.12 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 872.2797 | 23.83 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 872.6747 | 22.44 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 873.5706 | 25.02 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 874.4005 | 22.88 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 875.2569 | 22.29 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 875.4953 | 24.33 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 875.5331 | 25.55 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 875.5862 | 25.71 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 877.5074 | 25.32 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 877.5097 | 25.48 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 878.5313 | 24.21 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 879.5213 | 25.85 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 879.5216 | 26.08 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 879.5276 | 24.92 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 879.5909 | 25.1 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 879.5913 | 24.77 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 879.5959 | 25.09 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 881.2728 | 22.36 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 881.2748 | 22.32 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 881.5310 | 25.86 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 881.5390 | 25.55 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 881.5699 | 25.12 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 881.5710 | 24.93 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 881.5750 | 24.77 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 881.6052 | 25.15 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 881.6099 | 25.36 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 881.6123 | 25.36 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 882.2983 | 3.68 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 882.5334 | 23.87 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 883.4987 | 24.52 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 883.6281 | 25.87 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 884.1186 | 23.21 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 884.5482 | 24.2 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 885.5180 | 24.73 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 887.5179 | 24.3 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 887.5304 | 25.13 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 887.5358 | 25.32 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 887.5359 | 25.32 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 890.1417 | 23.22 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 893.5362 | 24.15 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 894.1432 | 22.96 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 895.5544 | 24.51 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 895.5544 | 24.51 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 897.5165 | 24.96 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 897.5715 | 24.77 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 897.6498 | 25.86 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 898.5606 | 24.49 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 899.4986 | 24.27 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 899.5029 | 24.21 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 899.5874 | 25.19 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 899.5880 | 25.19 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 900.6540 | 26.67 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 901.5081 | 24.45 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 901.5165 | 25.42 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 901.5169 | 24.51 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 901.5183 | 25.25 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 901.6022 | 25.88 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 903.2903 | 22.77 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 903.5212 | 24.95 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 903.5217 | 24.95 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 903.5235 | 24.8 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 903.5246 | 25.55 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 905.5362 | 25.26 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 905.5381 | 24.95 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 907.2906 | 22.48 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 907.4802 | 24.56 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 909.2097 | 22.06 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 909.2105 | 22.15 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 909.3046 | 22.74 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 909.3061 | 22.77 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 909.5229 | 24.64 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 909.5570 | 24.85 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 911.5265 | 25.21 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 912.5716 | 24.8 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 913.5258 | 24.42 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 913.5454 | 25.47 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 915.5405 | 24.89 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 915.5707 | 26.02 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 915.6050 | 25.85 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 919.4934 | 25.12 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 919.4947 | 25.3 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 919.5476 | 24.34 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 919.5549 | 24.44 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 921.5680 | 24.64 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 923.2538 | 22.48 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 923.5822 | 24.99 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 923.5866 | 25.19 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 923.5883 | 25.19 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 924.5043 | 23.77 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 924.6603 | 25.98 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 925.5113 | 24.36 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 925.5920 | 25.57 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 925.9494 | 22.62 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 926.6710 | 26.78 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 927.4942 | 24.61 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 927.5195 | 25.37 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 927.5292 | 24.85 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 927.5304 | 24.69 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 928.0840 | 22.64 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 928.0873 | 22.91 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 929.2348 | 22.44 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 929.2734 | 22.18 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 929.5119 | 24.59 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 929.5373 | 26.09 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 929.5377 | 25.88 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 929.5399 | 25.1 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 930.0971 | 22.89 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 931.5519 | 25.57 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 933.5258 | 24.26 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 933.5278 | 24.54 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 934.6460 | 22.44 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 935.2534 | 22.43 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 935.5383 | 25.02 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 936.3696 | 22.88 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 938.5225 | 23.97 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 939.1516 | 22.86 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 939.5406 | 24.57 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 939.6030 | 25.33 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 940.2662 | 24.12 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 940.2664 | 23.83 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 940.6605 | 22.44 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 941.5578 | 25.02 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 941.6204 | 25.99 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 942.3844 | 22.88 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 943.2446 | 22.3 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 943.4820 | 24.33 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 943.5100 | 25.55 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 943.5712 | 25.71 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 943.6427 | 27.02 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 946.5170 | 24.2 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 947.5090 | 25.85 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 947.5095 | 26.08 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 947.5141 | 24.92 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 947.5558 | 24.76 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 947.5905 | 25.09 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 949.2605 | 22.36 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 949.2630 | 22.32 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 949.5271 | 25.55 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 949.5888 | 25.36 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 950.5157 | 23.87 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 951.4921 | 24.52 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 951.6119 | 25.87 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 952.1058 | 23.22 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 952.5352 | 24.2 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 953.5031 | 24.73 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 955.3793 | 8.07 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 955.5001 | 24.3 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 955.5155 | 25.13 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 955.5205 | 25.32 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 955.5207 | 25.32 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 955.5610 | 25.42 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 956.1169 | 23.23 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 956.1177 | 22.97 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 957.5185 | 24.51 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 958.1257 | 23.22 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 961.5173 | 24.15 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 963.5387 | 24.51 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 963.5424 | 24.51 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 965.2342 | 22.37 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 965.4970 | 24.95 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 965.5541 | 24.78 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 967.5688 | 25.19 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 968.6395 | 26.68 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 969.4971 | 24.45 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 969.5007 | 25.27 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 969.5011 | 25.43 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 969.5051 | 24.49 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 969.5892 | 25.88 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 970.1927 | 1.03 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 971.5074 | 24.96 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 971.5086 | 24.95 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 971.5098 | 24.82 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 971.5116 | 25.56 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 971.5154 | 25.76 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 973.5187 | 25.27 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 973.5199 | 24.95 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 973.7578 | 26.4 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 975.2779 | 22.48 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 975.4742 | 24.57 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 975.5005 | 24.43 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 975.6107 | 23.71 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 977.1990 | 22.14 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 977.1995 | 22.14 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 977.2918 | 22.75 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 977.2935 | 22.77 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 977.3608 | 8.07 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 977.5053 | 24.65 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 977.5287 | 24.87 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 979.1411 | 2.35 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 979.5175 | 25.2 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 980.5525 | 24.8 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 981.5130 | 24.42 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 981.5284 | 25.27 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 981.5345 | 25.47 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 981.5391 | 25.47 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 983.5271 | 24.88 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 983.5452 | 26.02 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 984.1740 | 1.04 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 984.6239 | 23.58 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 985.5484 | 25.19 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 987.5363 | 24.26 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 987.5450 | 24.44 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 988.3991 | 22.68 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 989.5020 | 24.95 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 989.5057 | 24.79 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 989.5513 | 24.64 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 991.5725 | 25.19 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 992.1726 | 1.03 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 993.4930 | 24.36 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 993.5655 | 23.71 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 993.5712 | 25.57 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 994.6577 | 26.79 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 995.4761 | 24.61 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 995.5095 | 25.39 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 995.5133 | 24.85 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 995.5138 | 25.58 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 995.5153 | 24.69 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 995.5221 | 24.7 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 996.0592 | 22.91 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 996.0627 | 22.65 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 996.6145 | 22.44 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 997.5230 | 26.1 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 997.5239 | 25.88 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 997.5257 | 25.09 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 1172.0586 | 1.39 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 1734.7130 | 11.56 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOSYLAMINE (CAS# 4229-38-3); (M+CL)- | 0.61 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | (S)-2-AMINO-3-(3-HYDOXY-4-OXO-4H-PYRIDIN-1-YL)PROPANOATE OR L-MIMOSINE (CAS# 500-44-7); (M-H)- | 0.86 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | GDPMANNOSE (CAS# ); (M-H)- | 0.86 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | PROPENOATE (CAS# 79-10-7); (M-H)- | 1.13 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | UDP-N-ACETYL-D-GLUCOSAMINE (CAS# 528-04-1); (M-H)- | 1.52 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 2'-DEOXYINOSINE (CAS# 890-38-0); (M+CL)- | 1.81 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 3.94 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 3.94 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | (S)-3-METHYL-2-OXOPENTANOATE (CAS# 1460-34-0); (M-H)- | 4.37 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | 4-HYDROXY-2-QUINOLINECARBOXYLIC ACID-KRYNURENIC ACID (CAS# 492-27-3); (M-H)- | 4.98 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001155 | N-ACETYL-L-LEUCINE (CAS# 1188-21-2); (M-H)- | 7.23 | Minutes | ST000741 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |